Showing 12,041 - 12,060 results of 42,320 for search '(( 50 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ) OR ( a point decrease ))', query time: 0.90s Refine Results
  1. 12041

    Dynamics of Ca<sup>2+</sup> using <i>PLC</i> as a parameter for doses of <i>a</i> ≤ 1 <i>μ</i>g/ml of A<i>β</i>. by Joseph Minicucci (10047331)

    Published 2021
    “…<b>C</b> shows the two parameter bifurcation diagram when both <i>PLC</i> and <i>a</i> are varied. Note that only the small doses of <i>a</i> are considered and the region of oscillations shifts to the right as <i>a</i> decreases and <i>PLC</i> increases. …”
  2. 12042
  3. 12043
  4. 12044
  5. 12045
  6. 12046
  7. 12047
  8. 12048
  9. 12049

    The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors by T. Ghiasi (10910038)

    Published 2021
    “…<p>Robust and reliable QSAR models were developed to predict half-maximal inhibitory concentration (IC<sub>50</sub>) values of hepatitis C virus NS3/4A protease inhibitors from the Monte Carlo technique. 524 HCV NS3/4A protease inhibitors were extracted from the scientific literature to create a reasonably large set. …”
  10. 12050

    Uptake of the fluorescent glucose analog 2-NBDG is mediated by SGLT2 in KPT2 cells. by Meiyan Jiang (438439)

    Published 2014
    “…Increasing doses of (C–F) D-glucose (molar ratios of 1∶0, 1∶1, 1∶50 or 1∶1000 [2-NBDG/D-glucose]), or (G–J) phlorizin (molar ratios of 1∶0, 1∶1, 1∶10 or 1∶50 [2-NBDG/phlorizin]) dose-dependently decreased 2-NBDG fluorescence in KPT2. …”
  11. 12051

    The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice by Michael Bobardt (238998)

    Published 2020
    “…These findings demonstrate for the first time that an inhibitor of apoptosis protein antagonist enhances in a statistically manner the effects of an immune check point inhibitor on antiviral immunity and on HIV load reduction in tissues of humanized mice, suggesting that the combination of two distinct classes of immunomodulatory agents constitutes a promising anti-HIV immunotherapeutic approach.…”
  12. 12052
  13. 12053

    Fraction of cells with repression kinetics cannot explain the faster response upon repeated repression. by Lea Schuh (7144421)

    Published 2022
    “…<p>(A) Left: a model for cells without repression kinetics composed of basal GFP production (r<sub>basal</sub>) and degradation (r<sub>deg</sub>). …”
  14. 12054

    The Continuum in 5‑Fluorocytosine. Toward Salt Formation by Cecília C. P. da Silva (1755475)

    Published 2016
    “…Thermal analysis evidence that the salt formation decreases the melting point of the new compounds, ranking this molecule as a coformer candidate to improve the physical properties of other drugs.…”
  15. 12055

    Change of IF-ANA titers and the presence of ADrA in patients treated with anti-TNF inhibitors. by Ayano Mori (9455431)

    Published 2020
    “…Solid lines indicate the patients whose IF-ANA titers at the endpoint of the observation increased as compared with that of the starting point. Dashed lines indicate the patients whose titers were stable or decreased. …”
  16. 12056
  17. 12057
  18. 12058

    Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells... by Somayeh Fani (2967933)

    Published 2016
    “…<p><b>(A, B) Quantitative study of gene expression, (C) western blot analysis of protein markers of the apoptosis pathway in MCF-7 treated cells with a concentration of 2.5 μg/mL (IC</b><sub><b>50</b></sub><b>) respectively</b>. …”
  19. 12059

    Inflammatory cells and expression of IL-17, IL-23, IL-22 and IFN-γ before and during treatment with IMQ 5% cream or MAL-PDT. by Cristina Pellegrini (4382356)

    Published 2017
    “…<p>(A) Number of inflammatory cells increased significantly during the inflammatory phase of IMQ treatment (p<0.01) and the early time point of MAL-PDT treatment, while decreased at the late time point (*p<0.05). …”
  20. 12060

    Peer-assisted learning after onsite, low-dose, high-frequency training and practice on simulators to prevent and treat postpartum hemorrhage and neonatal asphyxia: A pragmatic tria... by Cherrie Lynn Evans (6091451)

    Published 2018
    “…Overall, 107, 195, and 199 providers were observed at three time points during 1,716 births across 44 facilities. Uterotonic coverage within one minute increased from: full group: 8% (CI 4%‒12%) to 50% (CI 42%‒59%); partial group: 19% (CI 9%‒30%) to 42% (CI 31%‒53%); and control group: 11% (5%‒7%) to 51% (40%‒61%). …”